Anti-integrin alpha(v) therapy improves cardiac fibrosis after myocardial infarction by blunting cardiac PW1(+) stromal cells

Bouvet, M; Claude, O; Roux, M; Skelly, D; Masurkar, N; Mougenot, N; Nadaud, S; Blanc, C; Delacroix, C; Chardonnet, S; Pionneau, C; Perret, C; Yaniz-Galende, E; Rosenthal, N; Tregouet, DA; Marazzi, G; Silvestre, JS; Sassoon, D; Hulot, JS

Hulot, JS (corresponding author), Univ Paris, INSERM, PARCC, 56 Rue Leblanc, F-75015 Paris, France.

SCIENTIFIC REPORTS, 2020; 10 (1):

Abstract

There is currently no therapy to limit the development of cardiac fibrosis and consequent heart failure. We have recently shown that cardiac fibrosis ......

Full Text Link